Apollo Medical Intrinsic Value – APOLLO MEDICAL Reports Record Q2 2023 Results, Revenues Increase 29.1% YOY and Net Income Up 15.5%
August 11, 2023
☀️Earnings Overview
APOLLO MEDICAL ($NASDAQ:AMEH) reported that on June 30 2023, their total revenue for the second quarter of FY2023 was USD 348.2 million – a 29.1% increase compared to the same period in FY2022 – and net income was USD 13.2 million, a 15.5% rise from the previous year.
Analysis – Apollo Medical Intrinsic Value
GoodWhale is the perfect tool to analyze APOLLO MEDICAL‘s financials. Using our proprietary Valuation Line, we can accurately calculate the fair value of APOLLO MEDICAL’s share to be around $54.6. Currently, APOLLO MEDICAL stock is traded at $38.1, which means that it is undervalued by 30.3% compared to its fair value. This presents a great opportunity for investors to acquire APOLLO MEDICAL shares at a discounted rate. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Apollo Medical. More…
| Total Revenues | Net Income | Net Margin |
| 1.3k | 49.69 | 4.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Apollo Medical. More…
| Operations | Investing | Financing |
| 65.81 | -7.11 | -20.09 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Apollo Medical. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.03k | 442.9 | 12.16 |
Key Ratios Snapshot
Some of the financial key ratios for Apollo Medical are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 24.9% | 40.7% | 8.8% |
| FCF Margin | ROE | ROA |
| 3.5% | 12.7% | 7.0% |
Peers
The healthcare industry is highly competitive, with Apollo Medical Holdings Inc competing against some of the largest companies in the world.
However, Apollo has been able to maintain a strong position in the industry through its innovative products and services. The company has a strong focus on research and development, which has allowed it to bring new and innovative products to market. Additionally, Apollo has a strong marketing and sales force that has helped it to gain market share.
– HealthCare Global Enterprises Ltd ($BSE:539787)
HealthCare Global Enterprises Ltd has a market cap of 41.71B as of 2022, a Return on Equity of 13.62%. The company is a leading provider of healthcare services in India with a network of over 30 hospitals across the country. The company offers a comprehensive range of services including medical and surgical care, diagnostics, and preventive healthcare.
– Cano Health Inc ($NYSE:CANO)
Cano Health Inc is a healthcare services company that operates primary care and specialty care clinics in the United States. The company has a market cap of 828.58M as of 2022 and a Return on Equity of -2.88%. Cano Health Inc provides healthcare services to patients through its network of primary care and specialty care clinics. The company offers a range of services including primary care, specialty care, and behavioral health services. Cano Health Inc also provides pharmacy services and operates a laboratory.
– Dhanvantri Jeevan Rekha Ltd ($BSE:531043)
Dhanvantri Jeevan Rekha Ltd is a publicly traded company with a market cap of 64.14M as of 2022. The company’s Return on Equity is 3.31%. Dhanvantri Jeevan Rekha Ltd is engaged in the business of providing healthcare services in India. The company offers a wide range of services including medical consultation, diagnostics, surgery, and other treatments.
Summary
APOLLO MEDICAL released their Q2 FY2023 financial results on June 30th, 2023, with a significant increase in their total revenue and net income. Total revenue was reported to be USD 348.2 million, a 29.1% year-over-year increase, while net income was USD 13.2 million, up 15.5% from the previous year. Overall, this is an encouraging sign of growth for the company and suggests potential investor opportunities in the near future.
